|
|
Volumn 349, Issue 21, 2003, Pages 2078-2079
|
|
Treatment of HCV-Related Mantle-Cell Lymphoma with Ribavirin and Pegylated Interferon Alfa [8]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
CHLORAMBUCIL;
FLUDARABINE;
MITOXANTRONE;
RECOMBINANT ALPHA INTERFERON;
RIBAVIRIN;
RITUXIMAB;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW BIOPSY;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER REGRESSION;
CANCER SURGERY;
CLINICAL FEATURE;
COLONOSCOPY;
COMPUTER ASSISTED TOMOGRAPHY;
DIAGNOSTIC PROCEDURE;
DISEASE COURSE;
DRUG EFFICACY;
FOLLOW UP;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOPHENOTYPING;
LABORATORY TEST;
LETTER;
LIVER CELL;
LYMPHOMA CELL;
MANTLE CELL LYMPHOMA;
MONONUCLEAR CELL;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RAJI CELL;
TREATMENT OUTCOME;
AGED;
ANTIVIRAL AGENTS;
CELL LINE, TUMOR;
DRUG THERAPY, COMBINATION;
HEPATITIS C;
HUMANS;
INTERFERON-ALPHA;
LYMPHOMA, B-CELL;
LYMPHOMA, MANTLE-CELL;
MALE;
RIBAVIRIN;
SPLENIC NEOPLASMS;
VIRAL LOAD;
|
|
EID: 0344064143
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200311203492121 Document Type: Letter |
|
Times cited : (49)
|
|
References (3)
|
